bioRxiv Science⌕ Search

Biology subjects

Erlebach, L.

Publications and source records attributed to Erlebach, L..

4 recordsLinked to original sources

Inflammatory proteostasis reprogramming creates a lysosomal bottleneck for microglial aggregate clearance

Efficient clearance of extracellular protein aggregates by microglia is essential for maintaining brain homeostasis and limiting the accumulation of pathological proteins during neurodegeneration. However, how inflammatory activation affects the ability of microglia to internalize and degrade these aggregates remains incompletely understood. Here, we show that lipopolysaccharide (LPS)-induced inflammatory activation impairs the degradation of extracellularly-acquired -synuclein (-Syn) and Tau aggregates while largely preserving their uptake. Mechanistically, Toll-like receptor 4 (TLR4) activation induces translational reprogramming and increases intracellular proteostatic demand, while inhibition of protein synthesis restores -Syn degradation without preventing inflammatory Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-{kappa}B) activation. Despite largely preserved canonical autophagic flux, inflammatory stimulation is associated with reduced expression of lysosomal proteins, including cathepsin D, suggesting insufficient lysosomal adaptation to increased intracellular demand. Consistent with this model, pharmacological activation of transcription factor EB (TFEB) restores aggregate degradation, indicating that the impairment can be overcome by enhancing lysosomal function. Supporting its potential relevance to human disease, microglial -Syn deposits in brain tissue from patients with dementia with Lewy bodies show limited spatial association with cathepsin D-positive structures. Together, our findings identify a demand-driven lysosomal bottleneck through which inflammatory activation compromises aggregate degradation without substantially affecting uptake, highlighting lysosomal adaptation as a critical determinant of microglial aggregate clearance during neuroinflammation.

cell biology↗

Prevention of Transgene Silencing During Human PluripotentStem Cell Differentiation

While high and stable transgene expression can be achieved in undifferentiated pluripotent stem cells, conventional transgene expression systems are often silenced upon differentiation. Silencing occurs with both randomly integrated transgenes, introduced via transposase or lentiviral methods, and with transgenes targeted to specific genomic sites, including at commonly used safe harbor loci. The challenge to robustly express experimental transgenes in differentiated pluripotent stem cells is a major bottleneck in the field for applications such as CRISPR screening. Here, we conducted a comparative analysis to systematically evaluate the impact of various promoters, transcriptional regulatory elements, insulators, and genomic integration sites on transgene silencing during neuronal differentiation. Our findings reveal that specific combinations of promoters and transcriptional stability elements are able to prevent transgene silencing during differentiation, whereas chromatin insulators had less impact on silencing and three novel safe harbor integration sites performed similarly to the CLYBL locus. Guided by these insights we developed the PiggyBac vector TK4, which showed complete resistance to transgene silencing across various neuronal and microglial differentiation protocols from six different pluripotent stem cell lines, as independently confirmed by seven different laboratories. This construct will be highly useful for assays requiring stable transgene expression during differentiation, and holds the potential for broad applications in various research fields.

neuroscience↗

The Neurolipid Atlas: a lipidomics resource for neurodegenerative diseases uncovers cholesterol as a regulator of astrocyte reactivity impaired by ApoE4

Lipid changes in the brain have been implicated in many neurodegenerative diseases including Alzheimers Disease (AD), Parkinsons disease and Amyotrophic Lateral Sclerosis. To facilitate comparative lipidomic research across brain-diseases we established a data commons named the Neurolipid Atlas, that we have pre-populated with novel human, mouse and isogenic induced pluripotent stem cell (iPSC)-derived lipidomics data for different brain diseases. We show that iPSC-derived neurons, microglia and astrocytes display distinct lipid profiles that recapitulate in vivo lipotypes. Leveraging multiple datasets, we show that the AD risk gene ApoE4 drives cholesterol ester (CE) accumulation in human astrocytes recapitulating CE accumulation measured in the human AD brain. Multi-omic interrogation of iPSC-derived astrocytes revealed that cholesterol plays a major role in astrocyte interferon-dependent pathways such as the immunoproteasome and major histocompatibility complex (MHC) class I antigen presentation. We show that through enhanced cholesterol esterification ApoE4 suppresses immune activation of astrocytes. Our novel data commons, available at neurolipidatlas.com, provides a user-friendly tool and knowledge base for a better understanding of lipid dyshomeostasis in neurodegenerative diseases.

neuroscience↗

A novel miR-99b-5p-Zbp1 pathway in microglia contributes to the pathogenesis of schizophrenia

Schizophrenia is a psychiatric disorder that is still not readily treatable. Pharmaceutical advances in the treatment of schizophrenia have mainly focused on the protein coding part of the human genome. However, the vast majority of the human transcriptome consists of non-coding RNAs. MicroRNAs are small non-coding RNAs that control the transcriptome at the systems level. In the present study we analyzed the microRNAome in blood and postmortem brains of controls and schizophrenia patients and found that miR-99b-5p was downregulated in both the prefrontal cortex and blood of patients. At the mechanistic level we show that inhibition of miR-99b-5p leads to schizophrenia-like phenotypes in mice and induced inflammatory processes in microglia linked to synaptic pruning. The miR-99b-5p-mediated inflammatory response in microglia depended on Z-DNA binding protein 1 (Zbp1) which we identified as a novel miR-99b-5p target. Antisense oligos (ASOs) against Zbp1 ameliorated the pathological phenotypes caused by miR-99b-5p inhibition. In conclusion, we report a novel miR-99b-5p-Zbp1 pathway in microglia that contributes to the pathogenesis of schizophrenia. Our data suggest that strategies to increase the levels of miR-99b-5p or inhibit Zbp1 could become a novel therapeutic strategy.

neuroscience↗